Neuroprosthetics Market Size, Top Share, Demand

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Neuroprosthetics Market Size Analysis

Global Neuroprosthetics Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Input Neuroprosthetics
  1. By Value
3. Output Neuroprosthetics
  1. By Value
4. Closed-loop/Adaptive Neuroprosthetics
  1. By Value
By Component
1. Introduction
  1. Component By Value
2. Implantable Device
  1. By Value
3. External Wearable Unit
  1. By Value
4. Software & Algorithms
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Deep Brain Stimulation
  1. By Value
3. Spinal Cord Stimulation
  1. By Value
4. Vagus Nerve Stimulation
  1. By Value
5. Sacral Nerve Stimulation
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Motor Neuron Disorders
  1. By Value
  2. Parkinson’s Disease
    1. Parkinson’s Disease By Value
  3. Epilepsy
    1. Epilepsy By Value
3. Physiological Disorders
  1. By Value
  2. Auditory Disorders
    1. Auditory Disorders By Value
  3. Ophthalmic Disorders
    1. Ophthalmic Disorders By Value
  4. Others
    1. Others By Value
4. Cognitive & Psychiatric Disorders
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Input Neuroprosthetics
  1. By Value
3. Output Neuroprosthetics
  1. By Value
4. Closed-loop/Adaptive Neuroprosthetics
  1. By Value
By Component
1. Introduction
  1. Component By Value
2. Implantable Device
  1. By Value
3. External Wearable Unit
  1. By Value
4. Software & Algorithms
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Deep Brain Stimulation
  1. By Value
3. Spinal Cord Stimulation
  1. By Value
4. Vagus Nerve Stimulation
  1. By Value
5. Sacral Nerve Stimulation
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Motor Neuron Disorders
  1. By Value
  2. Parkinson’s Disease
    1. Parkinson’s Disease By Value
  3. Epilepsy
    1. Epilepsy By Value
3. Physiological Disorders
  1. By Value
  2. Auditory Disorders
    1. Auditory Disorders By Value
  3. Ophthalmic Disorders
    1. Ophthalmic Disorders By Value
  4. Others
    1. Others By Value
4. Cognitive & Psychiatric Disorders
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Input Neuroprosthetics
    1. By Value
  3. Output Neuroprosthetics
    1. By Value
  4. Closed-loop/Adaptive Neuroprosthetics
    1. By Value
2. By Component
  1. Introduction
    1. Component By Value
  2. Implantable Device
    1. By Value
  3. External Wearable Unit
    1. By Value
  4. Software & Algorithms
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Brain Stimulation
    1. By Value
  3. Spinal Cord Stimulation
    1. By Value
  4. Vagus Nerve Stimulation
    1. By Value
  5. Sacral Nerve Stimulation
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Motor Neuron Disorders
    1. By Value
    2. Parkinson’s Disease
      1. Parkinson’s Disease By Value
    3. Epilepsy
      1. Epilepsy By Value
  3. Physiological Disorders
    1. By Value
    2. Auditory Disorders
      1. Auditory Disorders By Value
    3. Ophthalmic Disorders
      1. Ophthalmic Disorders By Value
    4. Others
      1. Others By Value
  4. Cognitive & Psychiatric Disorders
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Input Neuroprosthetics
  1. By Value
3. Output Neuroprosthetics
  1. By Value
4. Closed-loop/Adaptive Neuroprosthetics
  1. By Value
By Component
1. Introduction
  1. Component By Value
2. Implantable Device
  1. By Value
3. External Wearable Unit
  1. By Value
4. Software & Algorithms
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Deep Brain Stimulation
  1. By Value
3. Spinal Cord Stimulation
  1. By Value
4. Vagus Nerve Stimulation
  1. By Value
5. Sacral Nerve Stimulation
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Motor Neuron Disorders
  1. By Value
  2. Parkinson’s Disease
    1. Parkinson’s Disease By Value
  3. Epilepsy
    1. Epilepsy By Value
3. Physiological Disorders
  1. By Value
  2. Auditory Disorders
    1. Auditory Disorders By Value
  3. Ophthalmic Disorders
    1. Ophthalmic Disorders By Value
  4. Others
    1. Others By Value
4. Cognitive & Psychiatric Disorders
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Input Neuroprosthetics
    1. By Value
  3. Output Neuroprosthetics
    1. By Value
  4. Closed-loop/Adaptive Neuroprosthetics
    1. By Value
2. By Component
  1. Introduction
    1. Component By Value
  2. Implantable Device
    1. By Value
  3. External Wearable Unit
    1. By Value
  4. Software & Algorithms
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Brain Stimulation
    1. By Value
  3. Spinal Cord Stimulation
    1. By Value
  4. Vagus Nerve Stimulation
    1. By Value
  5. Sacral Nerve Stimulation
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Motor Neuron Disorders
    1. By Value
    2. Parkinson’s Disease
      1. Parkinson’s Disease By Value
    3. Epilepsy
      1. Epilepsy By Value
  3. Physiological Disorders
    1. By Value
    2. Auditory Disorders
      1. Auditory Disorders By Value
    3. Ophthalmic Disorders
      1. Ophthalmic Disorders By Value
    4. Others
      1. Others By Value
  4. Cognitive & Psychiatric Disorders
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Input Neuroprosthetics
  1. By Value
3. Output Neuroprosthetics
  1. By Value
4. Closed-loop/Adaptive Neuroprosthetics
  1. By Value
By Component
1. Introduction
  1. Component By Value
2. Implantable Device
  1. By Value
3. External Wearable Unit
  1. By Value
4. Software & Algorithms
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Deep Brain Stimulation
  1. By Value
3. Spinal Cord Stimulation
  1. By Value
4. Vagus Nerve Stimulation
  1. By Value
5. Sacral Nerve Stimulation
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Motor Neuron Disorders
  1. By Value
  2. Parkinson’s Disease
    1. Parkinson’s Disease By Value
  3. Epilepsy
    1. Epilepsy By Value
3. Physiological Disorders
  1. By Value
  2. Auditory Disorders
    1. Auditory Disorders By Value
  3. Ophthalmic Disorders
    1. Ophthalmic Disorders By Value
  4. Others
    1. Others By Value
4. Cognitive & Psychiatric Disorders
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Input Neuroprosthetics
    1. By Value
  3. Output Neuroprosthetics
    1. By Value
  4. Closed-loop/Adaptive Neuroprosthetics
    1. By Value
2. By Component
  1. Introduction
    1. Component By Value
  2. Implantable Device
    1. By Value
  3. External Wearable Unit
    1. By Value
  4. Software & Algorithms
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Brain Stimulation
    1. By Value
  3. Spinal Cord Stimulation
    1. By Value
  4. Vagus Nerve Stimulation
    1. By Value
  5. Sacral Nerve Stimulation
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Motor Neuron Disorders
    1. By Value
    2. Parkinson’s Disease
      1. Parkinson’s Disease By Value
    3. Epilepsy
      1. Epilepsy By Value
  3. Physiological Disorders
    1. By Value
    2. Auditory Disorders
      1. Auditory Disorders By Value
    3. Ophthalmic Disorders
      1. Ophthalmic Disorders By Value
    4. Others
      1. Others By Value
  4. Cognitive & Psychiatric Disorders
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Input Neuroprosthetics
  1. By Value
3. Output Neuroprosthetics
  1. By Value
4. Closed-loop/Adaptive Neuroprosthetics
  1. By Value
By Component
1. Introduction
  1. Component By Value
2. Implantable Device
  1. By Value
3. External Wearable Unit
  1. By Value
4. Software & Algorithms
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Deep Brain Stimulation
  1. By Value
3. Spinal Cord Stimulation
  1. By Value
4. Vagus Nerve Stimulation
  1. By Value
5. Sacral Nerve Stimulation
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Motor Neuron Disorders
  1. By Value
  2. Parkinson’s Disease
    1. Parkinson’s Disease By Value
  3. Epilepsy
    1. Epilepsy By Value
3. Physiological Disorders
  1. By Value
  2. Auditory Disorders
    1. Auditory Disorders By Value
  3. Ophthalmic Disorders
    1. Ophthalmic Disorders By Value
  4. Others
    1. Others By Value
4. Cognitive & Psychiatric Disorders
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Input Neuroprosthetics
    1. By Value
  3. Output Neuroprosthetics
    1. By Value
  4. Closed-loop/Adaptive Neuroprosthetics
    1. By Value
2. By Component
  1. Introduction
    1. Component By Value
  2. Implantable Device
    1. By Value
  3. External Wearable Unit
    1. By Value
  4. Software & Algorithms
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Brain Stimulation
    1. By Value
  3. Spinal Cord Stimulation
    1. By Value
  4. Vagus Nerve Stimulation
    1. By Value
  5. Sacral Nerve Stimulation
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Motor Neuron Disorders
    1. By Value
    2. Parkinson’s Disease
      1. Parkinson’s Disease By Value
    3. Epilepsy
      1. Epilepsy By Value
  3. Physiological Disorders
    1. By Value
    2. Auditory Disorders
      1. Auditory Disorders By Value
    3. Ophthalmic Disorders
      1. Ophthalmic Disorders By Value
    4. Others
      1. Others By Value
  4. Cognitive & Psychiatric Disorders
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Input Neuroprosthetics
  1. By Value
3. Output Neuroprosthetics
  1. By Value
4. Closed-loop/Adaptive Neuroprosthetics
  1. By Value
By Component
1. Introduction
  1. Component By Value
2. Implantable Device
  1. By Value
3. External Wearable Unit
  1. By Value
4. Software & Algorithms
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Deep Brain Stimulation
  1. By Value
3. Spinal Cord Stimulation
  1. By Value
4. Vagus Nerve Stimulation
  1. By Value
5. Sacral Nerve Stimulation
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Motor Neuron Disorders
  1. By Value
  2. Parkinson’s Disease
    1. Parkinson’s Disease By Value
  3. Epilepsy
    1. Epilepsy By Value
3. Physiological Disorders
  1. By Value
  2. Auditory Disorders
    1. Auditory Disorders By Value
  3. Ophthalmic Disorders
    1. Ophthalmic Disorders By Value
  4. Others
    1. Others By Value
4. Cognitive & Psychiatric Disorders
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Input Neuroprosthetics
    1. By Value
  3. Output Neuroprosthetics
    1. By Value
  4. Closed-loop/Adaptive Neuroprosthetics
    1. By Value
2. By Component
  1. Introduction
    1. Component By Value
  2. Implantable Device
    1. By Value
  3. External Wearable Unit
    1. By Value
  4. Software & Algorithms
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Brain Stimulation
    1. By Value
  3. Spinal Cord Stimulation
    1. By Value
  4. Vagus Nerve Stimulation
    1. By Value
  5. Sacral Nerve Stimulation
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Motor Neuron Disorders
    1. By Value
    2. Parkinson’s Disease
      1. Parkinson’s Disease By Value
    3. Epilepsy
      1. Epilepsy By Value
  3. Physiological Disorders
    1. By Value
    2. Auditory Disorders
      1. Auditory Disorders By Value
    3. Ophthalmic Disorders
      1. Ophthalmic Disorders By Value
    4. Others
      1. Others By Value
  4. Cognitive & Psychiatric Disorders
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Neuroprosthetics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Advanced Bionics AG
Axis Neuroscience
Blackrock Neurotech
Boston Scientific Corporation
Cognixion, Inc.
LivaNova PLC
MED‑EL Medical Electronics
Medtronic
Nevro Corp.
Retina Implant AG
Science Corporation
Second Sight Medical Products, Inc.
SensArs Neuroprosthetics
Sonova Holding AG
Synapse Biomedical Inc.
Synchron, Inc.
ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment